4//SEC Filing
ACADIA PHARMACEUTICALS INC 4
Accession 0001415889-17-000407
$ACADCIK 0001070494operating
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 8:37 PM ET
Size
5.4 KB
Accession
0001415889-17-000407
Insider Transaction Report
Form 4
Moore Terrence O
EVP, CHIEF COMMERCIAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2017-03-08+33,750→ 33,750 totalExercise: $36.54Exp: 2027-03-07→ Common Stock (33,750 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option vest and become exercisable on March 8, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070494
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 8:37 PM ET
- Size
- 5.4 KB